Recent achievements in cancer epigenetics include discovery of a central role for the H3K79 methyltransferase DOT1L in maintaining MLL-r leukemia, an aggressive malignancy recognized in 5–10% of human acute leukemia cases19,20. This evidence concerns the gene KMT2A and leukemia.